Anam Farzand | Molecular Biology | Best Researcher Award

Ms. Anam Farzand | Molecular Biology | Best Researcher Award

Sultan Zainal Abidin University | Malaysia 

Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies.

Profiles: Scopus | Orcid | Google Scholar | Researchgate

Featured Publications

Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2.

Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007.

Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27.

Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553.

Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).

Prof Dr. Girish Melkani | Molecular Biology | Excellence in Research

Prof Dr. Girish Melkani | Molecular Biology | Excellence in Research

Prof Dr. Girish Melkani, UAB, Heersink School of Medicine, United States

Dr. Girish C. Melkani is an Associate Professor of Pathology with a distinguished career focused on understanding the pathophysiological basis of human circadian/metabolic disorders linked with cardiovascular diseases, aging, and neurodegenerative diseases. His innovative work, utilizing Drosophila models, has contributed significantly to the fields of cardiometabolic disorders, sleep dysfunction, and protein misfolding diseases.

Profile 🌟

Orcid

Based on Girish C. Melkani’s biographical sketch, here’s a detailed analysis of his suitability for the “Excellence in Research” award, focusing on his strengths, areas for improvement, and a conclusion:

Strengths for the Award 💪

Circadian Rhythms and Cardiac Health: Melkani’s work on circadian rhythms and their impact on cardiac health, particularly through time-restricted feeding (TRF), represents a significant contribution to understanding age-related cardiovascular decline. His research has been published in high-impact journals like Science and Nature Communications.

Drosophila Models: The use of Drosophila models to study complex diseases such as Alzheimer’s Disease, cardiac amyloidosis, and laminopathies demonstrates his innovative approach. This model is particularly effective for studying genetic and physiological processes relevant to human health.

Protein Misfolding and Amyloid Diseases: Melkani’s research into protein misfolding and amyloid diseases, including Huntington’s Disease, provides critical insights into the mechanisms underlying these conditions and potential therapeutic targets.

Substantial Grant Support:

His research is supported by multiple NIH grants, including R01 and RF1 awards, highlighting the significant impact and continued relevance of his work. The diversity of his funding, ranging from circadian rhythms to metabolic disorders, reflects his broad expertise and the importance of his research.

Leadership and Mentorship:

Melkani’s leadership roles, including his position as co-leader of the Organismal Core at the UAB Nathan Shock Center, demonstrate his ability to guide and collaborate on high-impact research. His involvement in reviewing grants and serving on various study sections underscores his standing in the scientific community.

Recognition and Honors:

His numerous invitations to speak at prestigious conferences and workshops, such as SLEEP 2024 and the Society for Research on Biological Rhythms, attest to his influence and recognition in his field.

Areas for Improvement 🚀

Broader Dissemination of Research Findings:

While Melkani’s research is published in high-impact journals, efforts to engage with broader audiences, including non-specialist communities, could enhance the translation of his findings into public health benefits. Increased visibility in mainstream media or collaborations with public health organizations might be beneficial.

Interdisciplinary Collaboration:

Although Melkani has demonstrated effective collaboration within his field, expanding interdisciplinary partnerships with researchers in related areas such as behavioral science or clinical practice could enhance the applicability and impact of his findings.

Educational Contributions:

While his research achievements are notable, additional focus on educational contributions and outreach, such as developing new curricula or mentoring programs for students, could further strengthen his profile as a leading researcher.

Conclusion 🎯

Girish C. Melkani is highly suitable for the “Excellence in Research” award. His groundbreaking work on circadian rhythms, metabolic disorders, and protein misfolding, supported by substantial grant funding and published in leading journals, exemplifies research excellence. His leadership roles and recognition by the scientific community further underscore his impact.

Education 🎓

Dr. Melkani earned his B.Sc. in Chemistry and Biology in 1993 and his M.Sc. in Organic Chemistry in 1995 from Kumaun University, Nainital, India. He later pursued his Ph.D. in Chemistry with a focus on lipoproteins, oxidative stress, and atherosclerosis. His postdoctoral training involved studying heat shock proteins, chaperones, and contractile proteins, contributing to his expertise in cardiovascular and muscle diseases.

Experience 💼

Dr. Melkani has held several prestigious positions, including his current role as an Associate Professor at the University of Alabama Birmingham (UAB). He has also served as an Associate Professor at San Diego State University and a Visiting Scientist at renowned institutions like the Salk Institute and Sanford Burnham Prebys Medical Discovery Institute. His extensive experience spans over two decades of research and teaching in the fields of pathology and molecular biology.

Research Interests 🔬

Dr. Melkani’s research interests lie in exploring the mechanisms underlying circadian/metabolic disorders, cardiometabolic diseases, and proteinopathies. His work focuses on how genetic and lifestyle factors, such as circadian rhythms and time-restricted feeding, affect cellular and organismal physiology. His lab uses Drosophila models to study diseases like Alzheimer’s, laminopathies, and cardiovascular disorders, aiming to develop therapeutic interventions.

Awards & Honors 🏆

Dr. Melkani has received numerous awards and honors for his contributions to science, including recognition from the American Heart Association and invitations to speak at international conferences. He serves on several scientific committees and editorial boards, reflecting his leadership and influence in the field.

Publications Top notes 📚

Gill, S., Le, H., Melkani, G.C., & Panda, S. (2015). Time-restricted feeding attenuates age-related cardiac decline in Drosophila. Science. Cited by: 500+ articles. Link

Villanueva, J., Livelo, C., Trujillo, A., et al. (2019). Time-restricted feeding mitigates obesity and circadian disruption-induced skeletal muscle abnormalities. Nature Communications. Cited by: 300+ articles. Link

Melkani, G.C., Ramos, R., Bodmer, R., et al. (2013). Huntington’s disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart. PLoS Genetics. Cited by: 200+ articles. Link

Livelo, C., Guo, Y., Abou Daya, F., et al. (2023). Time-restricted feeding promotes muscle function through purine cycles and AMPK signaling in Drosophila obesity models. Nature Communications. Cited by: 150+ articles. Link